References
- Kyle R A, Rajkumar S V. Multiple myeloma. N Engl J Med 2004; 351: 1860–1873
- Hewell G M, Alexanian R. Multiple myeloma in young persons. Ann Intern Med 1976; 84: 441–443
- Rapoport A P, Rowe J M. Plasma cell dyscrasia in a 15-year-old boy: case report and review of the literature. Am J Med 1990; 89: 816–818
- Ishida T, Dorfman H D. Plasma cell myeloma in unusually young patients: a report of two cases and review of the literature. Skeletal Radiol 1995; 24: 47–51
- Blade J, Kyle R A, Greipp P R. Multiple myeloma in patients younger than 30 years. Arch Intern Med 1996; 156: 1463–1468
- Chen C C, Gan J P, Ho C H, Lin J S, Chiou H J, Lirng J F. Aggressive multiple myeloma with brain involvement in a young patient. J Clin Med Assoc 2003; 66: 177–180
- Greipp P R, San Miguel J, Durie B GM, Crowley J J, Barlogie B, Blade J, et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412–3420
- Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gharton J, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma subcommittee of the EBMT. Br J Haematol 1998; 102: 1115–1123
- Dimopoulos M A, Moulopoulos L, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic mutliple myeloma. Blood 2000; 96: 2037–2044
- Bergsagel P L, Kuehl W M, Zhan F, Sawyer J, Barlogie B, Shaughnessy J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005; 106: 296–303